Top Markets
#1 Black Phoenix Black Phoenix +354.71%
#2 Glidr Glidr +84.34%
#3 OpenEden OpenEden +71.47%
#4 Gold Park Gold Park +68.84%
#5 Akedo Akedo +55.26%
#6 BasedHype BasedHype +26.51%
#7 Cryptopia Cryptopia +21.54%
#8 Humanity Humanity +20.22%
#9 Avantis Avantis +19.35%
#10 Ether.fi Ether.fi +17.25%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Verisante Technology Inc. Verisante Technology Inc.

Verisante Technology Inc.

VRSEF
Kedudukan dalam Saham #40371
Verisante Technology Inc. presently lacks substantial business operations.... Verisante Technology Inc. presently lacks substantial business operations. Historically, the company focused on developing and manufacturing advanced diagnostic devices for cancer. Originally founded as T-Ray Science Inc., it adopted its current name, Verisante Technology Inc., in January 2011. The firm was established in 2006 and is headquartered in Vancouver, Canada.
Harga Saham
$0.0011
Disegerakkan terakhir: 2026-08-12
Modal Pasaran
$164.53K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-72.50%
Negara
CA
Perdagangan Verisante Technology Inc. (VRSEF)

Kategori

Healthcare
Sejarah pecahan saham untuk Verisante Technology Inc. (VRSEF)
Saham Verisante Technology Inc. (simbol: VRSEF) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 13, 2026.
Satu saham VRSEF yang dibeli sebelum Aug 13, 2026 kini bersamaan dengan 0 saham VRSEF.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 9 x285
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 9 x162
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 7 x127
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 2 x4
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 3 x12
US